10-Q: China Foods Holdings Reports Wider Loss, Margin Plunge

China Foods Holdings Ltd. reported a wider net loss and a significant drop in gross profit margin for the six months ended June 30, 2025, despite a substantial increase in revenue.

Summary

• Revenue for the six months ended June 30, 2025, increased significantly to $142,255, up from $27,617 in the prior year, driven by rising demand for healthcare products.
• Gross profit for the six-month period decreased to $15,585 from $20,176, with the gross profit margin plummeting from 73% to 11%.
• The decline in gross profit margin is attributed to higher cost of revenue, which outpaced revenue growth due to supply chain inefficiencies and inflationary pressures.
• Net loss for the six months ended June 30, 2025, widened to $200,907, compared to a net loss of $169,959 in the same period last year.
• The company reported a working capital deficit of $1,089,871 as of June 30, 2025.
• Cash and cash equivalents increased to $63,569 as of June 30, 2025, from $39,192 at December 31, 2024.
• Net cash used in operating activities increased to $186,613 for the six months ended June 30, 2025, from $115,750 in the prior year.
• Financing activities provided $216,549 in cash, primarily from advances from directors and related parties.
• Management concluded that disclosure controls and procedures were not effective as of June 30, 2025.

Sentiment

Score: 3

Explanation: Despite strong revenue growth, the company's financial health deteriorated significantly with a drastic drop in gross profit margin and a widening net loss. The substantial working capital deficit and reliance on related party financing for going concern, coupled with ineffective disclosure controls, indicate severe operational and financial challenges and high risk.

Positives

• Revenue for the six months ended June 30, 2025, saw a substantial increase to $142,255 from $27,617 in the prior year, indicating strong sales growth.
• There was a significant increase in demand for healthcare products during the period, which drove the revenue growth.
• Cash and cash equivalents increased to $63,569 as of June 30, 2025, from $39,192 at December 31, 2024.
• Management has secured legally binding, unconditional, and enforceable agreements with its controlling shareholder to provide financial support for at least the next 12 months, mitigating immediate going concern risks.

Negatives

• Net loss for the six months ended June 30, 2025, widened to $200,907, an increase from $169,959 in the comparable prior-year period.
• Gross profit significantly decreased to $15,585 for the six months ended June 30, 2025, from $20,176 in the prior year.
• Gross profit margin dramatically compressed from 73% to 11% for the six months ended June 30, 2025, primarily due to higher cost of revenue outpacing sales growth.
• The company reported a substantial working capital deficit of $1,089,871 as of June 30, 2025.
• Accumulated deficit increased to $2,332,451 as of June 30, 2025.
• Net cash used in operating activities increased, indicating a higher cash burn from core operations.
• Disclosure controls and procedures were deemed not effective, raising concerns about the reliability of financial reporting.

Risks

• The company incurred a net loss and has a significant working capital deficit, making its continuation as a going concern dependent on continued financial support from stockholders.
• Concentration of customers: For the three and six months ended June 30, 2025, two customers accounted for approximately 51% and 49% of total revenues, respectively, all located in the PRC.
• Concentration of vendors: For the three and six months ended June 30, 2025, two vendors accounted for approximately 77% and 14% of total purchases, respectively, all located in the PRC.
• Economic and political risks in the PRC, where major operations are conducted, could influence business, financial condition, and results of operations.
• Exchange rate risk due to fluctuations in HKD and RMB against the US$, which could impact reported profits.
• Recent trade tensions and high tariffs pose potential risks to the company's supply chain and pricing.
• Ineffective disclosure controls and procedures as of June 30, 2025, indicate a weakness in ensuring timely and accurate financial information.

Future Outlook

Management expects to continue relying on cash generated through financing from existing stockholders and private placements to fund operations and future acquisitions. Current cash and other liquidity sources are believed to be adequate for at least the next 12 months, supported by legally binding agreements with the controlling shareholder for financial support. The company is actively monitoring trade tensions and implementing strategies such as supplier diversification, local sourcing, and logistics optimization to mitigate potential impacts on its supply chain and pricing.

Management Comments

• "Management believes the existing stockholders will provide the additional cash to meet with the Company's obligations as they become due."
• "The Company continued to operate and fulfill contractual obligations during the period and has received substantial customer payments and has ongoing signed contracts that are expected to result in revenue recognition in the near future, supporting the continuity of its business operations."
• "Furthermore, the Company has entered into legally binding, unconditional, and enforceable agreements with its controlling shareholder to provide financial support sufficient to meet all obligations as they fall due for at least the next 12 months."
• "The shareholder has a demonstrated history of providing such support, including capital injections and shareholder loans in recent periods."
• "Managements liquidity forecasts indicate that the Company will have sufficient resources to fund its operations without reliance on external financing."
• "Accordingly, management has concluded that there is no substantial doubt about the Company's ability to continue as a going concern for at least 12 months from the date of issuance of these financial statements."
• "Our President and Principal Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were not effective."

Industry Context

The company operates in the health and wellness sector in China and Hong Kong, offering a range of products and services including supplements, healthy snacks, and nutritional consultation, alongside a wine business. The significant increase in healthcare product revenue suggests a robust demand within this segment. However, the company faces broader industry challenges, including recent trade tensions and high tariffs, which are impacting supply chains and pricing, necessitating strategic adjustments like supplier diversification and local sourcing.

Corporate Governance

Legal Proceedings

• There are no legal proceedings pending or threatened against the company or its officers, directors, or control persons of which management is aware.

Related Party Transactions

• The company received temporary advances from its directors and a related company for working capital purposes.
• As of June 30, 2025, the company owed $456,940 to its directors.
• As of June 30, 2025, the company owed $305,076 to a related company.
• As of June 30, 2025, the company owed $272,463 to a related party.
• These advances are unsecured, non-interest bearing, and due on demand.

Stakeholder Impact

• Shareholders: Face increased net loss, significant gross margin compression, and a worsening working capital deficit, which could negatively impact share value. The ineffective disclosure controls raise concerns about financial transparency.
• Customers: Continued revenue growth in healthcare products suggests ongoing demand and service provision.
• Suppliers/Vendors: The company has concentration risk with two major vendors, which could impact supply chain stability.
• Creditors: The substantial amounts owed to directors and related parties, along with the working capital deficit, indicate a reliance on internal financing rather than external creditors, potentially signaling higher risk for any future external debt providers.

Next Steps

• Continue to rely on cash generated through financing from existing stockholders and private placements of securities.
• Actively monitor trade tensions and implement strategies such as supplier diversification, local sourcing, and logistics optimization to mitigate impacts.

Key Dates

Recommendation

Despite a notable increase in revenue, the company's financial performance has severely deteriorated, marked by a drastic decline in gross profit margin from 73% to 11% and a widening net loss. The significant working capital deficit and continued reliance on related party financing for liquidity raise serious going concern doubts. Furthermore, the disclosure of ineffective disclosure controls and procedures indicates a fundamental weakness in financial reporting and transparency. These combined factors present a highly precarious financial position and substantial operational challenges, making the stock a high-risk investment with significant downside potential.

Keywords

Healthcare, Wellness, Supplements, Skincare, Nutritional Consultation, Wine Products, China Market, Hong Kong Market, SEC Filing, Quarterly Report, Financial Performance, Gross Margin, Net Loss, Working Capital Deficit, Going Concern, Related Party Financing, Internal Controls, Trade Tensions